MedTrace Logo

Persistent Postoperative Pain Incidence With Gabapentin Used

NCT02693821 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2023-02-06

No results posted yet for this study

Summary

The study's objective will be to evaluate the gabapentine efficiency in orally and long term used after painfully surgeries.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Gabapentin

gabapentin 300 mg per day, orally during 30 days

DRUG

Placebo

Placebo 300 mg per day, orally during 30 days

Sponsors & Collaborators

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • Francisco FB Bonofiglio, Doctor · Hospital Italiano de Buenos Aires

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-01-31
Completion
2022-06-30

Countries

  • Argentina

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693821 on ClinicalTrials.gov